Midlands Abdominal and Retroperitoneal Sarcoma Unit, Queen Elizabeth Hospital Birmingham, Edgbaston, Birmingham, B15 2TH, UK.
Midlands Abdominal and Retroperitoneal Sarcoma Unit, Queen Elizabeth Hospital Birmingham, Edgbaston, Birmingham, B15 2TH, UK.
Eur J Surg Oncol. 2021 Jul;47(7):1771-1777. doi: 10.1016/j.ejso.2021.01.021. Epub 2021 Feb 1.
This observational study aimed to evaluate the impact of intensity of radiological surveillance on survival following resection of retroperitoneal sarcoma.
Retrospective cohort study of patients undergoing primary resection of soft tissue sarcoma arising in the retroperitoneum, abdomen or pelvis at a single, high-volume sarcoma centre. Intensity of follow-up regimes up to 5 postoperative years were categorized as 'European Society for Medical Oncology (ESMO) compliant' (intense), or 'non-ESMO compliant' (less-intense). The primary outcome measure was overall survival (OS). The secondary outcome measures were disease-free survival (DFS) and reoperation rate. Analyses were stratified by high (grade 2 or 3) or low (grade 1) tumour grade.
Of 168 patients, 67.1% had high-grade and 32.9% had low-grade disease. Overall, 40.0% of patients had ESMO-compliant radiological follow-up (high-grade:25.7%, low-grade:66.7%). 41.7% of patients died and 48.2% suffered local or distant recurrence by cessation of follow up. Upon univariable analysis for high-grade tumours, ESMO compliance reduced DFS (p = 0.066) but had no impact on OS. There was no significant difference in the reoperation rate in patients with ESMO-compliant and non-compliant follow-up (p = 0.097). In low-grade tumours, ESMO compliance significantly reduced DFS (p < 0.001), but without effecting OS. In risk-adjusted models for high-grade tumours, ESMO compliant follow-up was associated with reduced OS (HR:3.47, 1.40-8.61, p = 0.007) and no difference in DFS. In low-grade tumours, there was no association between overall ESMO compliance and OS or DFS.
This study did not find a benefit for high-intensity radiological surveillance and overall survival in patients undergoing primary resection for high or low-grade retroperitoneal sarcoma.
本观察性研究旨在评估影像学监测强度对腹膜后肉瘤切除术后生存的影响。
对单一高容量肉瘤中心接受腹膜后、腹部或骨盆软组织肉瘤原发切除术的患者进行回顾性队列研究。将术后 5 年内的随访方案强度分为“符合欧洲肿瘤内科学会(ESMO)标准”(高强度)或“不符合 ESMO 标准”(低强度)。主要结局指标是总生存(OS)。次要结局指标是无病生存(DFS)和再手术率。分析按高(2 级或 3 级)或低(1 级)肿瘤分级分层。
在 168 例患者中,67.1%为高级别,32.9%为低级别疾病。总体而言,40.0%的患者接受了符合 ESMO 标准的影像学随访(高级别:25.7%,低级别:66.7%)。41.7%的患者死亡,48.2%的患者因随访结束而发生局部或远处复发。在高级别肿瘤的单变量分析中,ESMO 依从性降低了 DFS(p=0.066),但对 OS 没有影响。在 ESMO 依从性和非依从性随访的患者中,再手术率无显著差异(p=0.097)。在低级别肿瘤中,ESMO 依从性显著降低了 DFS(p<0.001),但对 OS 没有影响。在高级别肿瘤的风险调整模型中,ESMO 依从性随访与 OS 降低相关(HR:3.47,1.40-8.61,p=0.007),DFS 无差异。在低级别肿瘤中,整体 ESMO 依从性与 OS 或 DFS 之间无关联。
本研究未发现高强度影像学监测与接受腹膜后肉瘤原发切除术的高或低级别患者的总生存之间存在获益。